Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

PYMNTS.com and The Innovation Project 2014 Announce Heavy-Weight Lineup including Global Thought-Leaders; Michael Porter, Sir Terry Leahy, Russell Simmons, Jeremy Allaire and others

Business Wire January 8, 2014

Sales Agents Push Aflac Past $87 Million for Childhood Cancer

PR Newswire January 8, 2014

Isarna Therapeutics and Santaris Pharma Announce License Agreement for the Development of Next Generation Oligonucleotides to Treat TGF-Beta-Mediated Diseases

PR Newswire January 8, 2014

Knopp Biosciences and NIH to Collaborate in Evaluating Dexpramipexole in Patients with Hypereosinophilic Syndrome

Business Wire January 8, 2014

Weill Cornell Medical College Receives $75 Million Gift from Sandra and Edward Meyer and the Sandra and Edward Meyer Foundation to Create the Meyer Cancer Center at Weill Cornell

PR Newswire January 8, 2014

Novogen to Present at Biotech Showcase(TM) 2014

PR Newswire January 8, 2014

Sangamo BioSciences to Focus on Advancing ZFP Therapeutic Pipeline at J.P. Morgan Healthcare Conference

PR Newswire January 8, 2014

ZIOPHARM Oncology to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Globe Newswire January 8, 2014

Cancer Genetics, Inc. to Present at Two Investor Conferences in January

Globe Newswire January 8, 2014

Kadmon Corporation to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Marketwired January 8, 2014

bluebird bio to Present at the J.P.Morgan Healthcare Conference

Business Wire January 8, 2014

Promedior Attains Patient Enrollment Milestone in Phase 2 Clinical Study of PRM-151 in Myelofibrosis

Business Wire January 8, 2014

Promedior Appoints William Hodder as Vice President of Business Development

Business Wire January 8, 2014

BioLineRx and JHL Biotech to Collaborate on Type 1 Diabetes Antibody Treatment

PR Newswire January 8, 2014

Agile Therapeutics Appoints Dr. Elizabeth Ijeoma Onyemelukwe Garner as Chief Medical Officer

PR Newswire January 8, 2014

Neumedicines' Study Shows HemaMax, Not Neupogen (G-CSF), Improves Survival Outcomes Following Lethal Irradiation

Business Wire January 8, 2014

Origin Agritech Limited Reports Unaudited Financial Results for the Year Ended September 30, 2013

PR Newswire January 8, 2014

Genetic Technologies Announces New Record Growth in Number of BREVAGen(TM) Tests Received for December Quarter

Marketwired January 8, 2014

Research and Markets: Hydrogen and Fuel Cells 2014-2025: Forecasts, Technologies, Markets

Business Wire January 8, 2014

Nanomedicine Market is Expected to Reach USD 177.60 Billion Globally in 2019: Transparency Market Research

PR Newswire January 8, 2014